ClinicalTrials.gg
CompletedNCT07137000Updated Nov 9, 2026

The Effect of Art Therapy in Patients Undergoing Colorectal Cancer

An interventional study of Art therapy in Colon Cancer and Rectum Cancer, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Mar 2025, registered Jul 2025).
Updated Nov 9, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Colonic Neoplasms with a site in Turkey — 7 open to participants now, 11 under way, 2 of them phase 3. Colonic Neoplasms · Turkey.

Enrollment
8th of 16
96 · median 83
Started
2025
with 8 others
No phase
13 of 29
3 open now
Registered
21st of 29
by date

Among the 29 studies in Colonic Neoplasms with a site in Turkey, this one is the 8th largest by enrollment of the 16 interventional ones that give a count, is one of 9 that started in 2025, is one of 13 with no phase, and was the 21st registered.

Colonic Neoplasms

2,457 studies on the registry are indexed under Colonic Neoplasms; 456 are open to participants now.

Browse Colonic Neoplasms studies →

Open to participants now

7 of the 29 studies in Colonic Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 326 Colonic Neoplasms studies recruiting now, 202 (62%) set no upper age limit and 72 (22%) stop at 75 or younger; 19 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Colonic Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

With the development of modern techniques, art has become important in the provision of health services and has enabled individuals to better recognise themselves and their surroundings. The World Health Organisation states that art has an important role in improving health, preventing and treating diseases. Art therapy is a therapy method that includes various art branches such as music, painting, sculpture and is especially applied to individuals with oncological diseases. The place of art therapy in solving the negative biopsychosocial problems experienced by these individuals before and after surgery is increasing day by day. Although there are studies on art therapy in the literature, there is no study on art therapy after colorectal cancer surgery. Therefore, in this study, it is aimed to examine the effect of art therapy applied to patients undergoing colorectal surgery on pain, anxiety, hope and life satisfaction. The population of the study will consist of patients who underwent colorectal cancer surgery in Marmara University Pendik Training and Research Hospital General Surgery Service between December 2024 and June 2025, and the sample will consist of 96 patients who meet the research criteria and accept to participate in the study. Patients participating in the study will be divided into two equal groups as intervention and control group. In the preoperative period, the patients in the intervention and control groups will be informed about the study, written and verbal consent will be obtained from the participants who accept the study, and the patients will be asked to answer the Patient Identification Form, Herth Hope Scale and Life Satisfaction Scale. The haemodynamic parameters of the patients in the intervention group will be recorded at 14:00 on the 1st, 2nd and 3rd postoperative days, the art therapy activity they have determined will be applied for 40 minutes and the data will be obtained using the Visual Analogue Scale, State Anxiety Inventory, Herth Hope Scale and Satisfaction with Life Scale. Patients in the control group will receive only routine ward care and data will be collected on the same days and hours as the intervention group. The data obtained will be analysed with appropriate statistical methods using SPSS Windows 22.0 software. As a result of the study, it is thought that there will be an improvement in the pain, anxiety, hope and life satisfaction of the participants.

03

Conditions studied

  • Colon Cancer
  • Rectum Cancer

Keywords

  • surgical nursing
  • art therapy
  • pain
  • anxiety
  • hope
  • life satisfaction
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 18 and 70,
  • Planned colorectal cancer surgery,
  • Not receiving treatment (chemotherapy, radiotherapy),
  • No diagnosed psychiatric disorder,
  • No history of anxiolytic drug use,
  • Patients who volunteered to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Communication difficulties,
  • Mental deficiency,
  • Patients with dysfunction or disease in their upper extremities that may prevent them from performing art therapy practices
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Adjuvant and neoadjuvant

Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumor. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
96 participants (actual)

Study arms

  • No intervention
    Control group

    No application will be made to this group, and an evaluation will be made after routine nursing care.

  • Experimental
    İntervention group (Art Teraphy)

    Five different art therapy methods (bead jewelry making, pencil drawing, painting, mandala, clay figure making) will be applied to the people in this group.

    Other: Art therapy

Interventions

  • OtherArt therapy

    Five different art therapy methods (making bead jewelry, pencil drawing, painting, mandala, making clay figures) be used for people in this group.

06

What researchers measure

Primary outcomes

  1. First evaluation- Pain

    It is a one-dimensional scale used to numerically express pain intensity. This scale consists of a 10-cm-long ruler with the words "no pain" at one end and "unbearable pain" at the other. A score of 0 cm on the scale indicates no pain, while a score of 10 cm indicates unbearable pain. As the score on the scale increases, the pain intensity increases.

    Time frame: Patients' pain will be assessed on postoperative days 1, 2, and 3, and on day 10 of discharge. This study is expected to last a total of 6 months, with data collection on the specified days.

  2. Anxiety level

    The anxiety level of the patients will be determined using the State Anxiety Inventory. The scale consists of a total of 20 items. Each item is rated on a four-point Likert-type scale: (1) not at all, (2) a little, (3) a lot, and (4) completely. The total score obtained ranges from 20 to 80. Higher scores indicate higher anxiety.

    Time frame: Patients' anxiety will be assessed on postoperative days 1, 2, and 3, and on day 10 of discharge. This study is expected to last a total of 6 months, with data collection on the specified days.

  3. Hope Levels

    Patients' hope levels will be assessed using the Herth Hope Scale. The scale consists of 30 items and three subscales. Each item has response options of "Not at all appropriate," "Rarely appropriate," "Sometimes appropriate," and "Always appropriate." The total score for the scale ranges from 0 to 90, with higher scores indicating higher hope.

    Time frame: It will be evaluated one day before surgery, on the 3rd day after surgery, and on the 10th day after discharge.

  4. Life Satisfaction

    Patients' life satisfaction will be assessed using the Life Satisfaction Scale. The scale, consisting of five items addressing life satisfaction, has a Cronbach's alpha of 0.88. The possible score range is 5-25. A low score indicates that the individual has low life satisfaction.

    Time frame: It will be evaluated one day before surgery, on the 3rd day after surgery, and on the 10th day after discharge.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Sep 2025, 6 months.

Of 382 non-industry interventional studies with no phase under Colonic Neoplasms, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 55. This study's 6 months is below that.

Counting every sponsor, half of 404 studies reached it within 30 months; a quarter within 16 and three quarters within 51.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Dec 2025 → Sep 2025 and completion Dec 2025 → Sep 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2025
First posted
Aug 22, 2025
StartActual
Mar 1, 2025
Primary completionActual
Sep 30, 2025was Dec 2025
CompletionActual
Sep 30, 2025was Dec 2025
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 9, 2026
Primary completion
Dec 1, 2025→Sep 30, 2025 (actual)
Nov 9, 2026
Study completion
Dec 31, 2025→Sep 30, 2025 (actual)
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Active, not recruiting→Completed
    Primary completion Dec 1, 2025→Sep 30, 2025 (now actual)
    Study completion Dec 31, 2025→Sep 30, 2025 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07137000
Responsible party
Büşra Bozkurt (Principal Investigator, PhD Student, Nurse, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Aug 22, 2025
Start date
Mar 1, 2025
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Nov 9, 2026

Study contacts

Elif Gezginci Akpinar, Assoc. Prof., PhD
study director · Saglik Bilimleri Universitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion